U.K. regulator reportedly expected to greenlight Oxford-AstraZeneca vaccine this week
The United Kingdom's Medicines and Healthcare Products Regulatory Agency is preparing to approve the COVID-19 vaccine developed by the University of Oxford and AstraZeneca at some point next week, The Telegraph and The Times report.
British ministers are reportedly drawing up plans to roll out the vaccine by Jan. 4. The U.K. has already approved and administered the Pfizer-BioNTech vaccine, and the government reportedly wants 2 million people to receive either shot within two weeks in the hopes of easing intense lockdowns across the country prompted by a new coronavirus variant that may be more transmissible.
There have been discrepancies in the Oxford-AstraZeneca trials when it comes to the vaccine's efficacy, though it's considered safe. New data reportedly suggests the candidate ultimately proved to be as effective as the Moderna and Pfizer-BioNTech vaccines, which registered above 90 percent, but some experts remain skeptical. Tim O'Donnell
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
'His story should be here'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
'Not cross buns': the row over recipe revamps
Talking Point New versions of the Easter favourite have sparked controversy but sales are soaring
By Adrienne Wyper, The Week UK Published
-
The England kit: a furore over the flag
Why everyone's talking about Nike's redesign of the St George's Cross on the collar of the English national team's shirt has caused controversy
By The Week UK Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published
-
Anger may be a powerful motivator for tough goals, new study suggests
Speed Read Keeping your cool might actually be less efficient than letting your anger drive you
By Theara Coleman, The Week US Published
-
A tropical skin disease is making the rounds in the US
Speed Read Leishmaniasis is endemic to the country and can cause ulcers and disfiguration
By Devika Rao, The Week US Published